|
WO2018106980A1
|
|
Liposomal elinafide formulations and uses thereof
|
|
WO2018089481A1
|
|
Mitomycin c prodrug liposome formulations and uses thereof
|
|
WO2017053464A1
|
|
Improved stability of liposome formulations and uses thereof
|
|
BR112017025115A2
|
|
preparation of sufentanil citrate and sufentanil base
|
|
US2016250177A1
|
|
Modified docetaxel liposome formulations and uses thereof
|
|
US2016184232A1
|
|
Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
|
|
US2015335638A1
|
|
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
MX2017000023A
|
|
Process for preparing substituted phenylalkanes.
|
|
WO2016004170A1
|
|
Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides
|
|
MX2016015507A
|
|
Oxidative dearomatization of berbines.
|
|
US2015258279A1
|
|
Intrathecal baclofen pharmaceutical dosage forms and related delivery system
|
|
WO2016171723A1
|
|
Systems and methods for high humidity curing within tablet coating system
|
|
US2015253213A1
|
|
Medicament sachet leak testing system
|
|
US2015105466A1
|
|
Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products
|
|
US2015099772A1
|
|
Substituted berbines and their synthesis
|
|
MX2016003240A
|
|
Substituted berbines and their synthesis.
|
|
BR112016006129A2
|
|
preparation of radioiodinated 3-fluoropropyl-nor-beta-cit
|
|
US2014378498A1
|
|
Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
|
|
WO2015013046A1
|
|
Injector with piezo motor system with wave form tuning
|
|
CN105308687A
|
|
Process of generating germanium
|
